TLX.AX · TELIX PHARMACEUTICALS LIMITED
Australia · RS rating 67 · As of 2026-10-14
| Price | 15.34 AUD |
|---|---|
| 1-day change | -2.8% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 25 / 67 / 61 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 38 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +14.1% |
| Market cap (USD) | $3.7B |